(Q43274885)

English

In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.

scientific article published on 8 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

based on heuristic

inferred from title

bacterial isolate

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

C-Y Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C-L Lu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Y-T Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C-H Liao

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

8 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1437-1442

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19763644%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

https://scigraph.springernature.com/pub.10.1007/s10096-009-0801-x

0 references

In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EUCAST technical note on tigecycline

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19763644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43274885&oldid=1940265599"